Page last updated: 2024-11-02

pioglitazone and Hepatitis, Chronic

pioglitazone has been researched along with Hepatitis, Chronic in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Hepatitis, Chronic: INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors.

Research Excerpts

ExcerptRelevanceReference
" Using a murine model of steatohepatitis (mice fed a diet deficient in methionine and choline-MCD diet), we tested the effects of the insulin-sensitising, PPARgamma agonist drug pioglitazone (PGZ) on systemic and intrahepatic insulin sensitivity and on liver pathology."7.74Intrahepatic insulin resistance in a murine model of steatohepatitis: effect of PPARgamma agonist pioglitazone. ( Horsmans, YJ; Lebrun, VA; Leclercq, IA; Stärkel, P, 2007)
" Using a murine model of steatohepatitis (mice fed a diet deficient in methionine and choline-MCD diet), we tested the effects of the insulin-sensitising, PPARgamma agonist drug pioglitazone (PGZ) on systemic and intrahepatic insulin sensitivity and on liver pathology."3.74Intrahepatic insulin resistance in a murine model of steatohepatitis: effect of PPARgamma agonist pioglitazone. ( Horsmans, YJ; Lebrun, VA; Leclercq, IA; Stärkel, P, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Leclercq, IA1
Lebrun, VA1
Stärkel, P1
Horsmans, YJ1

Other Studies

1 other study available for pioglitazone and Hepatitis, Chronic

ArticleYear
Intrahepatic insulin resistance in a murine model of steatohepatitis: effect of PPARgamma agonist pioglitazone.
    Laboratory investigation; a journal of technical methods and pathology, 2007, Volume: 87, Issue:1

    Topics: Animals; Blood Glucose; Disease Models, Animal; Fatty Liver; Female; Hepatitis, Chronic; Hypoglycemi

2007
chemdatabank.com